LEMAITRE VASCULAR INC — Director's Dealing 2025

Dec 11, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2025-12-10

Reporting Person: O'Connor John James (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-12-10	Common Stock	A	533	—	Acquired	62340	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-12-10	Stock Option (Right to Buy)	$83.66	A	3431	Acquired	2030-12-10	Common Stock (3431)	Direct

Footnotes

F1: Represents a restricted stock unit award that vests on a time-based schedule as follows: 33 1/3% of the award vests on 12/1/2026, with the balance vesting in equal annual installments over the remaining two years.

F2: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years.